title: PBMC Healthy Control INF 11N HG-U133A

description: Healthy patient.

value: 4y, when sample taken


title: PBMC S. aureus INF 109 HG-U133A

status: Public on May 30 2009

type: RNA

city: Dallas

first: Damien

last: Chaussabel

state: TX

address: 3434 Live Oak

country: USA

institute: Baylor Institute for Immunology Research

description: The subject was infected with Staphylococcus aureus, methicillin-resistant.

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 System.

data_processing: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 500.

label: Biotin

molecule: total RNA

organism: Homo sapiens

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol.

extract_protocol: RNEasy Mini Kit

tag: age

value: 0.67y, when sample taken

tag: gender

value: Female

tag: race

value: Hispanic

tag: illness

value: Bacteremia, Skin/Soft Tissue Abscess

tag: treatment

value: Anti-staphylococcal antibiotic

tag: pathogen


title: bas1 knock-out mutant vs bas1 ade16 ade17 knock-out mutant (dye swap)

status: Public on May 15 2009

city: PARIS

first: sophie

last: lemoine

address: 46 rue d'Ulm

department: Biologie

country: France

institute: Ecole Normale Supérieure

description: Technical replicate 2 of 2 (dye swap).

hyb_protocol: 2µg of labelled cDNA is mixed with one volume of 2X GE buffer (Agilent) and 10% of blocking agent. The hybridization sample volume is dispense on the selected microarray and incubated overnight at 65°C in a hybridization oven (Agilent). The array slides are washed 1 minute in "wash 1 buffer" at room temperature and one minute in "wash 2 buffer" at 37°C. The array slides are then air dried and ready for scanning.

scan_protocol: Scanned on a genepix 4000B scanner (Axon)

data_processing:
Scanning software: GenePix Pro 6.1
Normalization using Goulphar WebTool http://transcriptome.ens.fr/goulphar/
Genepix flags are removed from the analysis. Spots are considered as saturating spot above 60000 and removed. Background is not subtracted from the main signal. Global Lowess normalisation method.

organism: Saccharomyces cerevisiae

source_name: Total RNA extracted from bas1 knock-out mutant strain labeled with Cyanine-5 (red).

label_protocol: 2 µg RNA are retro transcribed using Superscript III retro transcriptase and incorporation of dUTP amino-allyl for indirect labeling. The cDNA are purified using QiaQuick column (Quiagen) and incubated 1 hour at room temperature in presence of 0.05M NaBicarbonate and NHS-ester Cy5. The coupling is stoped by addition of hydroxylamine to a final concentration of 0.6M. Labeled cDNA are purified using QiaQuick column.

growth_protocol: Cell growth 24 hours at 30°C in SD medium (Casaminoacid 0.2%, Adenin 300µM, Uracil 200µM, Tryptophan 200µM) to an OD = 0.5

extract_protocol: Hot phenol extract procedure followed by RNEasy Mini Kit purification step (Quiagen)

tag: bas1 knock-out mat alpha bas1

value: :KanMX4 his3D1 leu2D0 ura3D0 strain

source_name: Total RNA extracted from bas1 ade16 ade17 knock-out mutant strain labeled with Cyanine-3 (green).

label_protocol: 2 µg RNA are retro transcribed using Superscript III retro transcriptase and incorporation of dUTP amino-allyl for indirect labeling. The cDNA are purified using QiaQuick column (Quiagen) and incubated 1 hour at room temperature in presence of 0.05M NaBicarbonate and NHS-ester Cy3. The coupling is stoped by addition of hydroxylamine to a final concentration of 0.6M. Labeled cDNA are purified using QiaQuick column.

tag: bas1 ade16 ade17 knock-out mat alpha bas1

value: :KanMX4 ade16::KanMX4 ade17::KanMX4 his3D1 leu2D0 ura3D0 strain


title: Atypical T-ALL #14

city: Memphis

first: Charles

middle: G

last: Mullighan

state: TN

address: 262 Danny Thomas Place

department: Pathology

institute: St Jude Children's Research Hospital

description: RNA extracted from tumor cells obtained at diagnosis

hyb_protocol: Detailed protocols are described at the associated website for Yeoh et al. 2002 (St. Jude Children's Research Hospital, Supplemental Data for All1)

label: biotin

source_name: RNA extracted from diagnostic leukemic blasts of T-cell precursor acute lymphoblastic leukemia

growth_protocol: RNA was extracted from cryopreserved mononuclear cell preparations of diagnostic bone marrow or peripheral blood from T-ALL cases

extract_protocol: Trizol

tag: cell type


title: Sepsis gram-negative V29

status: Public on Apr 01 2009

city: Glebe

first: Benjamin

middle: Man Piu

last: Tang

state: NSW

address: 12/29 Cook Street

department: Intensive Care Medicine

country: Australia

institute: Nepean Hospital

description: Validation set

hyb_protocol: Following fragmentation, 15ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 plus 2.0 arrays.  GeneChips were washed and stained in the Affymetrix Fluidics Station 450

scan_protocol: GeneChips were scanned using an Affymetrix GCS3000 7G 4C scanner with autoloader

data_processing: Affymetrix CEL files were imported into the RMA software (Bioconductor) to compute probeset summaries.  Quantile nomalization was used.

source_name: Circulating mononuclear cells

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix one-cycle labelling protocol from 1ug total RNA (Expression Analysis Technical Manual 2001, Affymetrix)

growth_protocol: After each blood sample was collected, mononuclear cells were purified using density gradient separation using Ficoll-Paque (Amersham).

extract_protocol: Total RNA extraction using guanidinium thiocyanate (Ambion) according to manufacturer's protocol.

treatment_protocol: Nil treatment given

tag: Sepsis

tag: Gram-Negative


title: Sepsis V27

description: Validation set


title: Sepsis gram-positive V30

description: Validation set

tag: Gram-Positive


title: Sepsis V28

description: Validation set


title: PBMC S. aureus INF 150 HG-U133A

value: 9y, when sample taken

value: Black

value: Bacteremia, Osteomyelitis, Suppurative Arthritis, Myositis


title: Sepsis V35

description: Validation set


title: Sepsis V31

description: Validation set


title: Sepsis gram-negative V22

description: Validation set


title: Control V26

description: Validation set

tag: Control


title: Control V23

description: Validation set


title: Sepsis gram-positive V33

description: Validation set


title: Atypical T-ALL #17

scan_protocol: Detailed protocols are described at the associated website for Yeoh et al. 2002 (St. Jude Children's Research Hospital, Supplemental Data for All1)

value: diagnostic leukemic blasts of T-cell precursor acute lymphoblastic leukemia


title: Sepsis gram-negative V34

description: Validation set


title: Sepsis gram-positive V32

description: Validation set


title: Sepsis gram-negative V14

description: Validation set


title: Sepsis gram-negative V19

description: Validation set


title: Sepsis gram-positive V25

description: Validation set


title: bas1 ade16 ade17 knock-out mutant vs bas1 knock-out mutant

description: Technical replicate 1 of 2.

source_name: Total RNA extracted from bas1 ade16 ade17 knock-out mutant strain labeled with Cyanine-5 (red).

source_name: Total RNA extracted from bas1 knock-out mutant strain labeled with Cyanine-3 (green).


title: Atypical T-ALL #36

label_protocol: Detailed protocols are described at the associated website for Yeoh et al. 2002 (St. Jude Children's Research Hospital, Supplemental Data for All1)


title: Sepsis gram-negative V16

description: Validation set


title: Sepsis mixed infection  V24

description: Validation set

tag: Mixed Infection


title: Sepsis gram-negative V18

description: Validation set


title: Sepsis V20

description: Validation set


title: Sepsis V15

description: Validation set


title: Sepsis gram-positive V17

description: Validation set


title: Sepsis V21

description: Validation set


title: Sepsis mixed infection  V12

description: Validation set


title: Control TC7

description: Training set


title: Control TC8

description: Training set


title: Control V7

description: Validation set


title: Control TC5

description: Training set


title: Sepsis gram-positive V4

description: Validation set


title: Control TC6

description: Training set


title: Sepsis mixed infection V13

description: Validation set


title: Sepsis mixed infection V10

description: Validation set


title: Control V3

description: Validation set


title: Sepsis mixed infection TM1

description: Training set


title: Sepsis V1

description: Validation set


title: Sepsis gram-negative V11

description: Validation set


title: Sepsis V6

description: Validation set


title: Control TC4

description: Training set


title: Sepsis gram-positive V5

description: Validation set


title: Sepsis mixed infection TM5

description: Training set


title: Control TC10

description: Training set


title: Control TC3

description: Training set


title: Control TC2

description: Training set


title: Sepsis mixed infection TM4

description: Training set


title: Control V2

description: Validation set


title: Control TC9

description: Training set


title: Control TC1

description: Training set


title: Control V9

description: Validation set


title: Sepsis mixed infection TM6

description: Training set


title: Sepsis mixed infection TM2

description: Training set


title: Sepsis gram-negative V8

description: Validation set


title: Sepsis mixed infection TM3

description: Training set


title: Sepsis gram-negative TN9

description: Training set


title: Sepsis gram-negative TN8

description: Training set


title: Sepsis gram-positive TP8

description: Training set


title: Sepsis gram-negative TN6

description: Training set


title: Sepsis gram-positive TP6

description: Training set


title: Sepsis gram-negative TN3

description: Training set


title: Sepsis gram-positive TP4

description: Training set


title: Sepsis gram-negative TN7

description: Training set


title: Sepsis gram-negative TN2

description: Training set


title: Sepsis gram-positive TP10

description: Training set


title: Sepsis gram-positive TP7

description: Training set


title: PBMC JDM 3 of 13

status: Public on Mar 25 2009

city: Oklahoma City

first: Bart

last: Frank

state: OK

institute: OMRF

description: Affymetrix

hyb_protocol: Affymetrix

scan_protocol: Affymetrix

data_processing: GCOS 5.0

source_name: PBMC

label_protocol: Affymetrix

extract_protocol: Trizol + RNEasy

tag: PBMC


title: PBMC JDM 5 of 13

description: Affymetrix


title: PBMC JDM 9 of 13

description: Affymetrix


title: Sepsis gram-negative TN5

description: Training set


title: Sepsis gram-positive TP5

description: Training set


title: Sepsis gram-positive TP9

description: Training set


title: PBMC JDM 6 of 13

description: Affymetrix


title: PBMC JDM 7 of 13

description: Affymetrix


title: PBMC JDM 12 of 13

description: Affymetrix


title: PBMC JDM 2 of 13

description: Affymetrix


title: PBMC JDM 10 of 13

description: Affymetrix


title: PBMC JDM 13 of 13

description: Affymetrix


title: PBMC JDM 11 of 13

description: Affymetrix


title: PBMC JDM 4 of 13

description: Affymetrix


title: Sepsis gram-negative TN1

description: Training set


title: Sepsis gram-negative TN4

description: Training set


title: PBMC JDM 8 of 13

description: Affymetrix


title: Sepsis gram-positive TP2

description: Training set


title: Sepsis gram-positive TP3

description: Training set


title: Sepsis gram-positive TP1

description: Training set


title: PBMC JDM 1 of 13

description: Affymetrix


title: C32 (COG study 9404)

status: Public on Jan 29 2009

city: Albuquerque

first: Stuart

middle: S.

last: Winter

state: NM

department: Pediatrics

institute: University of New Mexico Health Sciences Center

description: C= Complete Continous Remission

hyb_protocol: 15 ug aliquots of fragmented, labelled cRNA were hybridized to the U133 Plus 2 chip (Affymetrix)

scan_protocol: Affymerix microarray scanner (Hewlett Packard), gene fluorescence was captured using GeneChip software.

data_processing: The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and the RMA normalization method.

source_name: Primary T-ALL cells; newly diagnosed patient; Complete Continous Remission

label_protocol: Biotin-labed cRNA from 2.5 micrgrams of tissue using a one-step method usng Affymetrix technical approach

growth_protocol: Derived from bone marrow in newly diagnosed patients

extract_protocol: RNeasyMini Kit (Qiagen)

treatment_protocol: COG study 9404

tag: Newly diagnosed patient


title: C20 (COG study 9404)

description: C= Complete Continous Remission


title: C27 (COG study 9404)

description: C= Complete Continous Remission


title: C28 (COG study 9404)

description: C= Complete Continous Remission


title: C30 (COG study 9404)

description: C= Complete Continous Remission


title: C18 (COG study 9404)

description: C= Complete Continous Remission


title: C19 (COG study 9404)

description: C= Complete Continous Remission


title: C11 (COG study 9404)

description: C= Complete Continous Remission


title: C14 (COG study 9404)

description: C= Complete Continous Remission


title: C21 (COG study 9404)

description: C= Complete Continous Remission


title: C16 (COG study 9404)

description: C= Complete Continous Remission


title: C15 (COG study 9404)

description: C= Complete Continous Remission


title: C23 (COG study 9404)

description: C= Complete Continous Remission


title: C12 (COG study 9404)

description: C= Complete Continous Remission


title: C31 (COG study 9404)

description: C= Complete Continous Remission


title: C29 (COG study 9404)

description: C= Complete Continous Remission


title: C25 (COG study 9404)

description: C= Complete Continous Remission


title: C26 (COG study 9404)

description: C= Complete Continous Remission


title: C9 (COG study 9404)

description: C= Complete Continous Remission


title: C7 (COG study 9404)

description: C= Complete Continous Remission


title: C8 (COG study 9404)

description: C= Complete Continous Remission


title: C22 (COG study 9404)

description: C= Complete Continous Remission


title: C24 (COG study 9404)

description: C= Complete Continous Remission


title: C6 (COG study 9404)

description: C= Complete Continous Remission


title: C5 (COG study 9404)

description: C= Complete Continous Remission


title: C13 (COG study 9404)

description: C= Complete Continous Remission


title: C10 (COG study 9404)

description: C= Complete Continous Remission


title: C3 (COG study 9404)

description: C= Complete Continous Remission


title: C2 (COG study 9404)

description: C= Complete Continous Remission


title: C4 (COG study 9404)

description: C= Complete Continous Remission


title: F23 (COG study 9404)

description: F= failure (relapse)

source_name: Primary T-ALL cells; newly diagnosed patient; failure (relapse)


title: F19 (COG study 9404)

description: F= failure (relapse)


title: F18 (COG study 9404)

description: F= failure (relapse)


title: F6 (COG study 9404)

description: F= failure (relapse)


title: NR17 (COG study 9404)

description: NR =no response (induction failure)

source_name: Primary T-ALL cells; newly diagnosed patient; no response (induction failure)


title: NR26 (COG study 9404)

description: NR =no response (induction failure)


title: F3 (COG study 9404)

description: F= failure (relapse)


title: F22 (COG study 9404)

description: F= failure (relapse)


title: F20 (COG study 9404)

description: F= failure (relapse)


title: F15 (COG study 9404)

description: F= failure (relapse)


title: F12 (COG study 9404)

description: F= failure (relapse)


title: F24 (COG study 9404)

description: F= failure (relapse)


title: F1 (COG study 9404)

description: F= failure (relapse)


title: F13 (COG study 9404)

description: F= failure (relapse)


title: F16 (COG study 9404)

description: F= failure (relapse)


title: NR7 (COG study 9404)

description: NR =no response (induction failure)


title: NR5 (COG study 9404)

description: NR =no response (induction failure)


title: F11 (COG study 9404)

description: F= failure (relapse)


title: NR10 (COG study 9404)

description: NR =no response (induction failure)


title: NR4 (COG study 9404)

description: NR =no response (induction failure)


title: bone marrow or peripheral blood, TEL-AML1 + hyperdiploidy, patient 80

status: Public on Jan 26 2009

city: Rotterdam

first: Monique

last: Den Boer

address: POBox 2060

department: Pediatric Oncology

country: Netherlands

institute: Erasmus MC-Sophia Children's Hospital

description: Sample collected at diagnosis.

hyb_protocol: Following fragmentation, 10 ug of cRNA was hybridized for 16 hr at 45C on GeneChip Human Genome U133 Array Set HG-U133A. After sample hybridization, GeneChips were stained using phycoerythrin-conjugated streptavidine in an Affymetrix Fluidics Station 450.

scan_protocol: GeneChips were scanned using the GeneArray Scanner.

data_processing: The CEL files for these samples were read into R using the affy package and normalized at probe-level with vsn (Huber et al, Bioinformatics 2002). Measurements were summarized per probe set using median polish. To build the classifier that is subsequently validated on independent data obtained with the Affymetrix U133 Plus 2.0, the 22,277 probe sets contained in both arrays were selected prior to normalization, and both the COALL training cohort (GEO GSE13425) and the DCOG validation cohort (GEO GSE13351) were normalized together.

source_name: bone marrow or peripheral blood sample from child with acute lymphoblastic leukemia

label_protocol: Biotinylated cRNA was produced according tot the Affymetrix protocol with the ENZO IVT labeling kit, using 5 ug total RNA as input (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: no growth protocol was used

extract_protocol: Total RNA was isolated out of leukemic cells using Trizol reagent (GIBCO BRL, Life Technologies). Quality of RNA was checked using an Agilent 2100 Bio-analyzer.

treatment_protocol: no treatment protocol was used

tag: Precursor-B ALL, subtype

value: TEL-AML1 (+hyperdiploidy)


title: bone marrow or peripheral blood, hyperdiploid, patient 81

description: Sample collected at diagnosis.

tag: Precursor-B  ALL, subtype

value: Hyperdiploid


title: bone marrow or peripheral blood, hyperdiploid, patient 83

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 89

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 88

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 75

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 82

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 87

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 76

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 77

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 79

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 86

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 85

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 71

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 74

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 70

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 72

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 73

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 65

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 84

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 78

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 90

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 66

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 64

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 69

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 62

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 68

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 63

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 61

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 67

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 59

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 57

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 47

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 58

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 55

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 60

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 49

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 54

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 42

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 44

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 51

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 52

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 56

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 48

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 45

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 46

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 40

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 39

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 53

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 38

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 50

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 41

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 43

description: Sample collected at diagnosis.


title: patient 107

description: no additional information

hyb_protocol: Following fragmentation, 10 ug of cRNA was hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. After sample hybridization, GeneChips were stained using phycoerythrin-conjugated streptavidine in an Affymetrix Fluidics Station 450.

data_processing: The CEL files for these samples were read into R using the affy package and normalized at probe-level with vsn (Huber et al, Bioinformatics 2002). Measurements were summarized per probe set using median polish. For validation of the classifier built on U133A Affymetrix chips, the 22,277 probe sets contained in both arrays were selected prior to normalization, and both the COALL training cohort (GEO GSE13425) and the DCOG validation cohort (GEO GSE13351) were normalized together.

label_protocol: Biotinylated cRNA was produced by one-cycle target-labelling invitro-transcription procedure according to the standard Affymetrix protocol, using 1.6 ug total RNA as input (Expression Analysis Technical Manual, 2005, Affymetrix).

tag: sample collected at diagnosis

tag: precursor-B ALL, subtype

value: other


title: patient 105

description: no additional information


title: patient 103

description: no additional information


title: patient 104

description: no additional information


title: patient 101

description: no additional information


title: patient 100

description: no additional information


title: patient 106

description: no additional information


title: patient 102

description: no additional information


title: patient 99

description: no additional information


title: patient 96

description: no additional information


title: patient 92

description: no additional information


title: patient 97

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 33

description: Sample collected at diagnosis.

tag: T-ALL


title: bone marrow or peripheral blood, T-ALL, patient 29

description: Sample collected at diagnosis.


title: patient 94

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 35

description: Sample collected at diagnosis.


title: patient 91

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 26

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 31

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 36

description: Sample collected at diagnosis.


title: patient 98

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 27

description: Sample collected at diagnosis.


title: patient 93

description: no additional information


title: patient 90

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 34

description: Sample collected at diagnosis.


title: patient 95

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 30

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 28

description: Sample collected at diagnosis.


title: patient 89

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 22

description: Sample collected at diagnosis.


title: patient 88

description: no additional information


title: patient 87

description: no additional information


title: patient 86

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 25

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 32

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 23

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 24

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, TEL-AML1, patient 37

description: Sample collected at diagnosis.


title: patient 85

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 18

description: Sample collected at diagnosis.


title: patient 81

description: no additional information


title: patient 84

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 21

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 19

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 15

description: Sample collected at diagnosis.


title: patient 79

description: no additional information


title: patient 80

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 20

description: Sample collected at diagnosis.


title: patient 82

description: no additional information


title: patient 78

description: no additional information


title: patient 77

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 13

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 17

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 14

description: Sample collected at diagnosis.


title: patient 76

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 16

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 12

description: Sample collected at diagnosis.


title: patient 83

description: no additional information


title: patient 74

description: no additional information

value: MLL


title: patient 75

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 11

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 10

description: Sample collected at diagnosis.


title: patient 72

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 9

description: Sample collected at diagnosis.


title: patient 70

description: no additional information

value: BCR-ABL


title: patient 73

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 3

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 5

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 1

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 8

description: Sample collected at diagnosis.


title: patient 71

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 4

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, T-ALL, patient 7

description: Sample collected at diagnosis.


title: patient 69

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 6

description: Sample collected at diagnosis.


title: patient 68

description: no additional information


title: patient 63

description: no additional information

tag: precursor-B  ALL, subtype


title: patient 62

description: no additional information


title: bone marrow or peripheral blood, T-ALL, patient 2

description: Sample collected at diagnosis.


title: patient 67

description: no additional information


title: patient 66

description: no additional information


title: patient 65

description: no additional information


title: patient 64

description: no additional information


title: patient 61

description: no additional information


title: patient 58

description: no additional information


title: patient 57

description: no additional information


title: patient 56

description: no additional information


title: patient 46

description: no additional information


title: patient 43

description: no additional information


title: patient 60

description: no additional information


title: patient 59

description: no additional information


title: patient 53

description: no additional information


title: patient 52

description: no additional information


title: patient 54

description: no additional information


title: patient 51

description: no additional information


title: patient 55

description: no additional information


title: patient 50

description: no additional information


title: patient 48

description: no additional information


title: patient 44

description: no additional information


title: patient 42

description: no additional information


title: patient 45

description: no additional information


title: patient 49

description: no additional information


title: patient 40

description: no additional information


title: patient 41

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 185

description: Sample collected at diagnosis.


title: patient 47

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 188

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 187

description: Sample collected at diagnosis.


title: patient 38

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 189

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 190

description: Sample collected at diagnosis.


title: patient 39

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 186

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 184

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 180

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 178

description: Sample collected at diagnosis.


title: patient 37

description: no additional information


title: patient 36

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 183

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 175

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 181

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 174

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 182

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 177

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 179

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 173

description: Sample collected at diagnosis.


title: patient 34

description: no additional information


title: patient 35

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 169

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 168

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 176

description: Sample collected at diagnosis.


title: patient 32

description: no additional information


title: patient 33

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 172

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 165

description: Sample collected at diagnosis.


title: patient 31

description: no additional information


title: patient 30

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 171

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 167

description: Sample collected at diagnosis.


title: patient 29

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 166

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 164

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 170

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 163

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 161

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 160

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 162

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 158

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 155

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 159

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 157

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 156

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 151

description: Sample collected at diagnosis.


title: patient 28

description: no additional information


title: patient 26

description: no additional information


title: patient 25

description: no additional information


title: patient 27

description: no additional information


title: patient 24

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 153

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 148

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 150

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 152

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, MLL, patient 145

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, MLL, patient 146

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 149

description: Sample collected at diagnosis.


title: patient 18

description: no additional information


title: patient 20

description: no additional information


title: patient 19

description: no additional information


title: bone marrow or peripheral blood, pre-B ALL, patient 154

description: Sample collected at diagnosis.


title: patient 22

description: no additional information


title: bone marrow or peripheral blood, MLL, patient 144

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, pre-B ALL, patient 147

description: Sample collected at diagnosis.


title: patient 23

description: no additional information


title: patient 21

description: no additional information


title: bone marrow or peripheral blood, BCR-ABL + hyperdiploidy, patient 142

description: Sample collected at diagnosis.

value: BCR-ABL (+hyperdiploidy)


title: patient 17

description: no additional information


title: bone marrow or peripheral blood, BCR-ABL, patient 141

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, BCR-ABL, patient 140

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, MLL, patient 143

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (E-sub), patient 137

description: Sample collected at diagnosis.

value: E2A-rearranged (E-sub)


title: bone marrow or peripheral blood, BCR-ABL, patient 138

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (E-sub), patient 136

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 131

description: Sample collected at diagnosis.

value: E2A-rearranged (EP)


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 132

description: Sample collected at diagnosis.


title: patient 16

description: no additional information


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 130

description: Sample collected at diagnosis.


title: patient 15

description: no additional information


title: bone marrow or peripheral blood, E2A-rearranged (E-sub), patient 135

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, BCR-ABL, patient 139

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (E-sub), patient 134

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 129

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 128

description: Sample collected at diagnosis.


title: patient 12

description: no additional information


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 127

description: Sample collected at diagnosis.


title: patient 14

description: no additional information


title: patient 13

description: no additional information


title: bone marrow or peripheral blood, E2A-rearranged (E), patient 125

description: Sample collected at diagnosis.

value: E2A-rearranged (E)


title: patient 10

description: no additional information


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 126

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 123

description: Sample collected at diagnosis.


title: patient 9

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 124

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, E2A-rearranged (EP), patient 133

description: Sample collected at diagnosis.


title: patient 11

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 121

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 122

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 120

description: Sample collected at diagnosis.


title: patient 8

description: no additional information


title: patient 7

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 119

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 117

description: Sample collected at diagnosis.


title: patient 6

description: no additional information


title: patient 5

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 115

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 118

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 114

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 113

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 107

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 111

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 110

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 106

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 108

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 104

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 109

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 105

description: Sample collected at diagnosis.


title: patient 3

description: no additional information


title: patient 2

description: no additional information


title: patient 1

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 102

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 103

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 99

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 100

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 95

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 112

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 97

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 116

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 94

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 101

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 98

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 91

description: Sample collected at diagnosis.


title: patient 4

description: no additional information


title: bone marrow or peripheral blood, hyperdiploid, patient 96

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 93

description: Sample collected at diagnosis.


title: bone marrow or peripheral blood, hyperdiploid, patient 92

description: Sample collected at diagnosis.


title: 7327

status: Public on Jan 21 2009

city: Houston

first: Roel

last: Verhaak

address: 1400 Pressler St

department: Bioinformatics and Comp Bio

institute: MD Anderson Cancer Center

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.

hyb_protocol: Affymetrix protocol.

scan_protocol: Affymetrix protocol.

data_processing: MAS5 with global scaling to target value 100, followed by setting all values lower than 30 at 30, and then log2 transformation.

source_name: Blasts and mononuclear cells, AML patient

label_protocol: Affymetrix protocol.

extract_protocol: Total RNA was extracted by lysis with guanidium isothiocyanate followed by cesium chloride gradient purification.

tag: male, 62 years, RAEB-t, cytogenetic poor risk, CEBPA wild type


title: 7324

tag: female, 69 years, FAB M2, cytogenetic intermediate risk, CEBPA single mutant


title: 7321

tag: female, 61 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 7322

tag: male, 63 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 7161

tag: female, 74 years, FAB M1, cytogenetic risk unknown, CEBPA wild type


title: 7325

tag: male, 70 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type


title: 7148

tag: female, 75 years, FAB M1, cytogenetic intermediate risk, CEBPA double mutant


title: 7323

tag: male, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 7136

tag: male, 68 years, FAB M5, cytogenetic poor risk, CEBPA wild type


title: 6458

tag: male, 63 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 6457

tag: female, 65 years, FAB M2, cytogenetic good risk, CEBPA wild type


title: 6461

tag: female, 65 years, RAEB-t, cytogenetic poor risk, CEBPA wild type


title: 6454

tag: female, 63 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 7328

tag: female, 68 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type


title: 7118

tag: male, 65 years, FAB unknown, cytogenetic intermediate risk, CEBPA wild type


title: 7176

tag: male, 70 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 7084

tag: female, 64 years, FAB M2, cytogenetic risk unknown, CEBPA wild type


title: 7146

tag: male, 65 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 6455

tag: female, 72 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 6453

tag: male, 73 years, FAB M0, cytogenetic intermediate risk, CEBPA wild type


title: 7116

tag: male, 66 years, FAB unknown, cytogenetic intermediate risk, CEBPA wild type


title: 7117

tag: male, 67 years, FAB unknown, cytogenetic intermediate risk, CEBPA wild type


title: 6459

tag: male, 61 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 7165

tag: female, 62 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type


title: 6456

tag: female, 77 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 6462

tag: male, 70 years, FAB unknown, cytogenetic intermediate risk, CEBPA single mutant


title: 6452


title: 7326

tag: male, 61 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 6450

tag: male, 68 years, FAB M6, cytogenetic poor risk, CEBPA wild type


title: 6449

tag: male, 64 years, FAB M2, cytogenetic good risk, CEBPA wild type


title: 5355

tag: male, 71 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 5354

tag: male, 72 years, RAEB-t, cytogenetic poor risk, CEBPA wild type


title: 7167

tag: female, 67 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 5350

tag: female, 63 years, FAB M1, cytogenetic poor risk, CEBPA wild type


title: 6451

tag: female, 72 years, FAB M1, cytogenetic poor risk, CEBPA wild type


title: 5353

tag: female, 74 years, FAB M4, cytogenetic good risk, CEBPA wild type


title: 5351

tag: female, 66 years, FAB M4, cytogenetic poor risk, CEBPA wild type


title: 5349

tag: male, 61 years, RAEB-t, cytogenetic intermediate risk, CEBPA wild type


title: 5352

tag: female, 70 years, FAB M2, cytogenetic intermediate risk, CEBPA double mutant


title: 6357

tag: male, 61 years, FAB M1, cytogenetic poor risk, CEBPA wild type


title: 5287


title: 5289

tag: male, 67 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 5291

tag: male, 67 years, RAEB-t, cytogenetic intermediate risk, CEBPA wild type


title: 5290

tag: female, 63 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 4342

tag: male, 62 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 5292

tag: male, 67 years, FAB M2, cytogenetic poor risk, CEBPA wild type


title: 5348

tag: female, 68 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 3490

tag: male, 70 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 3492


title: 3488

tag: male, 61 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 3493

tag: female, 66 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: 3491

tag: male, 72 years, FAB M1, cytogenetic intermediate risk, CEBPA wild type


title: 3487

tag: female, 72 years, RAEB-t, cytogenetic good risk, CEBPA wild type


title: 3489

tag: female, 68 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 3486

tag: female, 65 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type


title: 5288

tag: male, 64 years, FAB M2, cytogenetic poor risk, CEBPA wild type


title: 3485

tag: male, 66 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 3331

tag: female, 77 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: 3332

tag: male, 65 years, FAB M2, cytogenetic good risk, CEBPA wild type


title: 3330

tag: female, 71 years, FAB M4, cytogenetic intermediate risk, CEBPA wild type


title: BCR-ABL-SNP-#7

status: Public on Oct 02 2008

first: Jeffery

last: Klco

hyb_protocol: As per manufacturer (Affymetrix)

scan_protocol: As per manufacturer (Affymetrix)

label_protocol: As per manufacturer (Affymetrix)

growth_protocol: Cryopreserved peripheral blood or bone marrow samples obtained at diagnosis

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

tag: B-progenitor ALL with BCR-ABL1 fusion


title: 3329

tag: female, 62 years, FAB M4, cytogenetic good risk, CEBPA wild type


title: Hyperdip>50-SNP-#1

tag: B-progenitor ALL with high hyperdiploidy (>50 chromosomes)


title: Hyperdip>50-SNP-#20


title: 1448

tag: male, 47 years, FAB M3, cytogenetic intermediate risk, CEBPA wild type


title: CN_AML Patient 152 (U133A)

status: Public on Aug 22 2008

city: Munich

first: Klaus

middle: H

last: Metzeler

address: Marchioninistr. 15

department: Department of Internal Medicine III

country: Germany

institute: University of Munich

description: AML, normal karyotype (training set) FAB M1; age =38 years; OS = 1176 days; status (0=alive/1=dead): 0

hyb_protocol: Sample hybridisation was performed for 16 hours according to standard Affymetrix protocols

scan_protocol: Samples were scanned using an Affymetrix GeneChip scanner

data_processing: Normalization was performed using the variance stabilizing normalization algorithm, and probe set expression values were calculated by the median polish method. Quality control consisted of visual inspection of the array image for artifacts, assessment of RNA degradation plots, and inspection of rank-vs.-residual plots after normalization and probe set  summarization.

source_name: bone marrow mononuclear cells

label_protocol: Biotin labeling of antisense cRNA was performed according to standard Affymetrix protocols

extract_protocol: Mononuclear cells from bone marrow (BM) or peripheral blood (PB) were enriched by Ficoll gradient centrifugation. Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA preparation and  in vitro transcription were performed according to standard Affymetrix protocols.

treatment_protocol: Pretreatment bone marrow or peripheral blood mononuclear cells from patients with newly diagnosed acute myeloid leukemia (AML) with a normal karyotype


title: CN_AML Patient 207 (U133 Plus 2.0)

status: Public on Aug 29 2008

description: no additional information

source_name: peripheral blood mononuclear cells

tag: AML normal karyotype (test set) FAB M1; age =77 years; OS = 815 days; status (0=alive/1=dead)


title: CN_AML Patient 134 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =66 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 133 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =70 years; OS = 19 days; status (0=alive/1=dead): 1


title: CN_AML Patient 136 (U133A)

description: AML, normal karyotype (training set) FAB M5; age =67 years; OS = 137 days; status (0=alive/1=dead): 1


title: CN_AML Patient 163 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =32 years; OS = 916 days; status (0=alive/1=dead): 0


title: CN_AML Patient 170 (U133 Plus 2.0)

description: no additional information

tag: MDS normal karyotype (test set) MDS RAEB; age =64 years; OS = 1280 days; status (0=alive/1=dead)


title: CN_AML Patient 147 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =62 years; OS = 209 days; status (0=alive/1=dead): 0


title: CN_AML Patient 237 (U133 Plus 2.0)

description: no additional information

tag: AML normal karyotype (test set) FAB M4; age =79 years; OS = 4 days; status (0=alive/1=dead)


title: CN_AML Patient 162 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =79 years; OS = 175 days; status (0=alive/1=dead): 1


title: CN_AML Patient 132 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =20 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 214 (U133 Plus 2.0)

description: no additional information

tag: AML normal karyotype (test set) FAB M4; age =75 years; OS = 40 days; status (0=alive/1=dead)


title: CN_AML Patient 224 (U133 Plus 2.0)

description: no additional information

tag: AML normal karyotype (test set) FAB M1; age =69 years; OS = 624 days; status (0=alive/1=dead)


title: CN_AML Patient 131 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =65 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 155 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =59 years; OS = 1176 days; status (0=alive/1=dead): 0


title: 6463

tag: female, 63 years, FAB M5, cytogenetic intermediate risk, CEBPA wild type


title: CN_AML Patient 187 (U133 Plus 2.0)

description: no additional information

tag: AML normal karyotype (test set) FAB M2; age =71 years; OS = 1118 days; status (0=alive/1=dead)


title: 2704

tag: male, 69 years, FAB M2, cytogenetic intermediate risk, CEBPA wild type


title: CN_AML Patient 118 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =39 years; OS = 608 days; status (0=alive/1=dead): 0


title: CN_AML Patient 130 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =74 years; OS = 284 days; status (0=alive/1=dead): 1


title: CN_AML Patient 129 (U133A)

description: AML, normal karyotype (training set) FAB M5; age =17 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 103 (U133A)

description: AML, normal karyotype (training set) FAB M0; age =44 years; OS = 741 days; status (0=alive/1=dead): 1


title: CN_AML Patient 135 (U133A)

description: AML, normal karyotype (training set) FAB M5; age =24 years; OS = 79 days; status (0=alive/1=dead): 1


title: CN_AML Patient 106 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =56 years; OS = 4 days; status (0=alive/1=dead): 1


title: CN_AML Patient 127 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =59 years; OS = 31 days; status (0=alive/1=dead): 1


title: CN_AML Patient 111 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =38 years; OS = 581 days; status (0=alive/1=dead): 0


title: CN_AML Patient 87 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =45 years; OS = 238 days; status (0=alive/1=dead): 1


title: CN_AML Patient 88 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =49 years; OS = 107 days; status (0=alive/1=dead): 1


title: CN_AML Patient 81 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =46 years; OS = 17 days; status (0=alive/1=dead): 1


title: CN_AML Patient 84 (U133A)

description: AML, normal karyotype (training set) FAB M5; age =39 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 65 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =81 years; OS = 41 days; status (0=alive/1=dead): 1


title: CN_AML Patient 91 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =47 years; OS = 416 days; status (0=alive/1=dead): 1


title: CN_AML Patient 82 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =58 years; OS = 77 days; status (0=alive/1=dead): 1


title: CN_AML Patient 63 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =69 years; OS = 86 days; status (0=alive/1=dead): 1


title: CN_AML Patient 66 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =47 years; OS = 285 days; status (0=alive/1=dead): 0


title: CN_AML Patient 67 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =76 years; OS = 1102 days; status (0=alive/1=dead): 1


title: CN_AML Patient 34 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =41 years; OS = 1176 days; status (0=alive/1=dead): 0


title: CN_AML Patient 30 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =54 years; OS = 75 days; status (0=alive/1=dead): 1


title: CN_AML Patient 31 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =78 years; OS = 4 days; status (0=alive/1=dead): 1


title: CN_AML Patient 43 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =33 years; OS = 293 days; status (0=alive/1=dead): 1


title: CN_AML Patient 25 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =61 years; OS = 33 days; status (0=alive/1=dead): 1


title: sample 77 _ GEP _ prepreB-CALL with MLL

status: Public on Apr 25 2008

city: Padova

first: Andrea

last: Zangrando

address: Via Giustiniani, 3

department: Woman and Child's Health

country: Italy

institute: University of Padova

description:
PAD_00170
Gene expression data from pediatric acute leukemia samples at diagnosis

hyb_protocol: Following fragmentation, 11 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450DX.

scan_protocol: GeneChips were scanned using the Scan GCS3000Dx.

data_processing: The data were analyzed using R software [www.r-project.org] with BioConductor package [www.bioconductor.org]

source_name: White blood human cells

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

extract_protocol: Lysis of the mononuclear cells followed by lysate homonogenization using a biopolymer shredding system in a microcentrifuge spin-column format followed by total RNA purification using selective binding columns

treatment_protocol: White blood cells were isolated through Ficoll-Hypaque density gradient centrifugation

tag: Leukemia samples

tag: Bone Marrow sample


title: sample 79 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00174
Gene expression data from pediatric acute leukemia samples at diagnosis

tag: Peripheral blood sample


title: CN_AML Patient 2 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =59 years; OS = 104 days; status (0=alive/1=dead): 0


title: sample 78 _ GEP _ CALL with t(12;21)

description:
PAD_00173
Gene expression data from pediatric acute leukemia samples at diagnosis


title: CN_AML Patient 20 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =66 years; OS = 8 days; status (0=alive/1=dead): 1


title: CN_AML Patient 19 (U133A)

description: AML, normal karyotype (training set) FAB M2; age =25 years; OS = 190 days; status (0=alive/1=dead): 1


title: sample 81 _ GEP _ prepreB-CALL with MLL

description:
PAD_00178
Gene expression data from pediatric acute leukemia samples at diagnosis


title: CN_AML Patient 13 (U133A)

description: AML, normal karyotype (training set) FAB M0; age =64 years; OS = 761 days; status (0=alive/1=dead): 1


title: sample 80 _ GEP _ prepreB-CALL with MLL

description:
PAD_00176
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 75 _ GEP _ prepreB-CALL with MLL

description:
PAD_00168
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 71 _ GEP _ CALL with t(12;21)

description:
PAD_00157
Gene expression data from pediatric acute leukemia samples at diagnosis


title: CN_AML Patient 5 (U133A)

description: MDS RAEB, normal karyotype (training set) MDS RAEB; age =61 years; OS = 275 days; status (0=alive/1=dead): 0


title: CN_AML Patient 1 (U133A)

description: AML, normal karyotype (training set) FAB M4; age =62 years; OS = 4 days; status (0=alive/1=dead): 1


title: sample 74 _ GEP _ CALL with t(12;21)

description:
PAD_00164
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 72 _ GEP _ prepreB-CALL with MLL

description:
PAD_00158
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 70 _ GEP _ CALL with t(12;21)

description:
PAD_00153
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 76 _ GEP _ CALL with t(12;21)

description:
PAD_00169
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 66 _ GEP _ CALL with t(12;21)

description:
PAD_00141
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 69 _ GEP _ CALL with t(12;21)

description:
PAD_00152
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 64 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00138
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 60 _ GEP _ prepreB-CALL with MLL

description:
PAD_00133
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 65 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00139
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 63 _ GEP _ CALL with t(12;21)

description:
PAD_00136
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 58 _ GEP _ prepreB-CALL with MLL

description:
PAD_00125
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 57 _ GEP _ prepreB-CALL with MLL

description:
PAD_00124
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 56 _ GEP _ prepreB-CALL with MLL

description:
PAD_00123
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 59 _ GEP _ prepreB-CALL with MLL

description:
PAD_00126
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 53 _ GEP _ prepreB-CALL with MLL

description:
PAD_00120
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 50 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00113
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 45 _ GEP _ prepreB-CALL with MLL

description:
PAD_00096
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 38 _ GEP _ prepreB-CALL with MLL

description:
PAD_00078
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 27 _ GEP _ CALL-preB without t(9;22)

description:
PAD_00059
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 20 _ GEP _ prepreB-CALL with MLL

description:
PAD_00049
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 11 _ GEP _ CALL with t(12;21)

description:
PAD_00032
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 15 _ GEP _ CALL with t(12;21)

description:
PAD_00041
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 36 _ GEP _ prepreB-CALL with MLL

description:
PAD_00076
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 42 _ GEP _ CALL with t(12;21)

description:
PAD_00089
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 18 _ GEP _ CALL with t(12;21)

description:
PAD_00046
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 7 _ GEP _ prepreB-CALL with MLL

description:
PAD_00027
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 47 _ GEP _ CALL with t(12;21)

description:
PAD_00109
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 24 _ GEP _ CALL with t(12;21)

description:
PAD_00054
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 52 _ GEP _ prepreB-CALL with MLL

description:
PAD_00116
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 12 _ GEP _ CALL with t(12;21)

description:
PAD_00033
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 8 _ GEP _ prepreB-CALL with MLL

description:
PAD_00028
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 14 _ GEP _ CALL with t(12;21)

description:
PAD_00040
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 48 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00110
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 31 _ GEP _ prepreB-CALL with MLL

description:
PAD_00068
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 37 _ GEP _ CALL with t(12;21)

description:
PAD_00077
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 19 _ GEP _ CALL with t(12;21)

description:
PAD_00047
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 26 _ GEP _ prepreB-CALL with MLL

description:
PAD_00058
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 22 _ GEP _ CALL-preB with t(9;22)

description:
PAD_00051
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 41 _ GEP _ CALL with t(12;21)

description:
PAD_00085
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 6 _ GEP _ prepreB-CALL with MLL

description:
PAD_00026
Gene expression data from pediatric acute leukemia samples at diagnosis


title: primary_ALL_155

status: Public on Mar 15 2008

first: William

middle: E

last: Evans

address: 332 N Lauderdale St

institute: St.Jude Children's Research Hospital

hyb_protocol: 15ug of labeled cRNA was fragmented and hybridized overnight at 45C to the selected chip. Hybridized cRNAs were washed and detected via streptavidin/phycoerythrin using the Affymetrix 450 Fluidics Station and recommended protocols.

scan_protocol: Results were visualized by laser scanner (Affymetrix GeneChip Scanner 3000).

source_name: ALL cells from pediatric diagnostic bone marrow, methotrexate treated

label_protocol: 5-10ug of RNA was reverse transcribed to double-stranded (ds) cDNA using an oligo-dT primer coupled to a T7 promoter.  In vitro transcription from the ds cDNA was carried out using T7 polymerase and incorporating a biotinylated ribonucleotide analog.

extract_protocol: TriReagent (MRC)


title: sample 5 _ GEP _ prepreB-CALL with MLL

description:
PAD_00025
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 4 _ GEP _ prepreB-CALL with MLL

description:
PAD_00024
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 3 _ GEP _ prepreB-CALL with MLL

description:
PAD_00023
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 1 _ GEP _ prepreB-CALL with MLL

description:
PAD_00021
Gene expression data from pediatric acute leukemia samples at diagnosis


title: sample 2 _ GEP _ prepreB-CALL with MLL

description:
PAD_00022
Gene expression data from pediatric acute leukemia samples at diagnosis


title: primary_ALL_109


title: primary_ALL_112


title: primary_ALL_104


title: primary_ALL_106


title: primary_ALL_121


title: primary_ALL_105


title: primary_ALL_110


title: primary_ALL_116


title: primary_ALL_120


title: primary_ALL_122


title: primary_ALL_123


title: primary_ALL_114


title: primary_ALL_108


title: primary_ALL_117


title: primary_ALL_115


title: primary_ALL_119


title: primary_ALL_118


title: primary_ALL_107


title: primary_ALL_102


title: primary_ALL_113


title: primary_ALL_103


title: primary_ALL_101


title: primary_ALL_98


title: primary_ALL_100


title: primary_ALL_99


title: primary_ALL_97


title: CN_AML Patient 22 (U133A)

description: AML, normal karyotype (training set) FAB M1; age =61 years; OS = 860 days; status (0=alive/1=dead): 0


title: primary_ALL_96


title: AML 6238

status: Public on Mar 12 2008

description: Blasts and mononuclear cells were purified from bone marrow or peripheral blood aspirates of AML patients. Samples contained 80-100 percent blast cells.

tag: disease state

value: Acute myeloid leukemia

tag: cell type

value: blasts and mononuclear cells

value: neg

tag: gender

value: female

tag: age

value: 30 years

tag: score

value: FAB M4

tag: risk

value: cytogenetic poor

tag: cebpa

value: wild type

tag: karyotype

value: Neg

tag: flt3 itd mutation

tag: flt3 tkd mutation

tag: n-ras mutation

tag: k-ras mutation

tag: evi1 expression

value: Pos

tag: cebpa mutation


title: AML 6242

value: male

value: 52 years

value: FAB M2

value: cytogenetic intermediate

value: NN


title: AML 6245

value: pos

value: 55 years


title: AML 7320

value: Acute myeloid leukemia

value: 34 years

value: FAB M5

tag: karyotype:


title: AML 6359

value: blasts and mononuclear cells

value: neg

value: 53 years

value: RAEB-t

value: MDS complex


title: AML 6361

value: 60 years

value: wild type

value: Neg


title: AML 5360

value: male

value: 29 years

value: FAB M1

value: cytogenetic poor


title: primary_ALL_30


title: AML 7417

value: FAB M4

value: cytogenetic intermediate

value: NN

value: Pos


title: AML 7414

value: Acute myeloid leukemia

value: female

value: 54 years

value: FAB M5


title: AML 7412

value: blasts and mononuclear cells

value: neg

value: 17 years

value: cytogenetic good


title: AML 7423

value: 40 years

value: FAB M0

value: wild type

value: Neg


title: AML 6240

value: 55 years

value: FAB M2

value: cytogenetic poor


title: AML 7419

value: male

value: 58 years

value: FAB M4

value: Complex


title: AML 6243

value: Acute myeloid leukemia

value: 18 years


title: AML 7418

value: blasts and mononuclear cells

value: pos

value: 46 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 7420

value: neg

value: 56 years

value: wild type

value: Pos


title: AML 7409

value: FAB M0

value: cytogenetic poor

value: Neg


title: AML 6244

value: female

value: 57 years

value: FAB M2


title: AML 7416

value: Acute myeloid leukemia

value: male

value: 55 years

value: FAB M4

value: Complex


title: AML 7421

value: blasts and mononuclear cells

value: 46 years

value: cytogenetic intermediate


title: AML 7479

value: neg

value: 56 years

value: Other


title: AML 7408

value: pos

value: FAB M1

value: wild type

value: NN

value: Pos


title: AML 5361

value: female

value: 28 years

value: FAB M2

value: cytogenetic poor

value: Neg


title: AML 7413

value: Acute myeloid leukemia

value: male

value: 59 years

value: FAB M5


title: AML 7411

value: blasts and mononuclear cells

value: neg

value: 54 years

value: cytogenetic intermediate


title: AML 7274

value: 37 years

value: FAB M3

value: cytogenetic good


title: AML 7410

value: 57 years

value: wild type

value: Pos


title: AML 7273

value: 22 years


title: AML 7187

value: 21 years

value: FAB M2


title: AML 7312

value: Acute myeloid leukemia

value: 33 years

value: RAEB

value: cytogenetic poor

value: MDS complex

value: Neg


title: AML 7190

value: blasts and mononuclear cells

value: neg

value: male

value: 58 years

value: FAB M6


title: AML 7272

value: pos

value: 48 years

value: Other


title: AML 7121

value: 49 years

value: unknown

value: wild type

value: failure

value: Pos


title: AML 7169

value: Acute myeloid leukemia

value: 54 years

value: FAB M2

value: cytogenetic intermediate


title: AML 7072

value: blasts and mononuclear cells

value: 60 years

value: FAB M4

value: cytogenetic poor

value: Neg


title: AML 7171

value: neg

value: male

value: 22 years

value: FAB unknown


title: AML 7188

value: 51 years

value: FAB M5

value: unknown


title: AML 7191

value: female

value: 45 years

value: wild type

value: Pos


title: AML 7077

value: Acute myeloid leukemia

value: 53 years

value: RAEB

value: cytogenetic intermediate

value: Other


title: AML 7168

value: blasts and mononuclear cells

value: pos

value: 33 years

value: NN

value: Neg


title: AML 7070

value: neg

value: 39 years

value: FAB M4


title: AML 7164

value: male

value: 48 years

value: FAB M1


title: AML 7079

value: 28 years

value: FAB M5

value: cytogenetic good

value: wild type


title: AML 7180

value: Acute myeloid leukemia

value: 38 years

value: cytogenetic intermediate

value: Pos


title: AML 7144

value: blasts and mononuclear cells

value: pos

value: 51 years


title: AML 7122

value: neg

value: female

value: 18 years

value: NN

value: Neg


title: AML 7120

value: FAB M1

value: cytogenetic poor


title: AML 7186

value: 40 years

value: FAB M2

value: unknown

value: failure


title: AML 7071

value: Acute myeloid leukemia

value: male

value: 50 years

value: wild type


title: AML 7078

value: blasts and mononuclear cells

value: 55 years

value: FAB M5

value: cytogenetic intermediate

value: Pos


title: AML 7076

value: neg

value: female

value: FAB M0


title: AML 7073

value: 37 years

value: FAB M4

value: NN

value: Neg


title: AML 7166

value: 44 years

value: cytogenetic poor


title: AML 7119

value: Acute myeloid leukemia

value: male

value: 57 years

value: FAB M2


title: AML 7067

value: blasts and mononuclear cells

value: pos

value: 42 years

value: FAB M1

value: wild type


title: AML 7065

value: neg

value: female

value: 45 years

value: cytogenetic intermediate

value: Pos


title: AML 7075

value: 55 years

value: FAB M4

value: single mutant

value: Other

value: Neg


title: AML 7074

value: Acute myeloid leukemia

value: NN


title: AML 7058

value: blasts and mononuclear cells

value: male

value: 54 years


title: AML 7056

value: 17 years

value: FAB M2

value: cytogenetic good


title: AML 7051

value: neg

value: female

value: 59 years

value: FAB M1

value: wild type


title: AML 6981

value: FAB M5

value: cytogenetic intermediate

value: Pos


title: AML 6891

value: 56 years

value: FAB M4

value: Neg


title: AML 6980

value: Acute myeloid leukemia

value: blasts and mononuclear cells


title: AML 6892

value: male

value: 21 years


title: AML 7052

value: 34 years

value: FAB M2

value: Other


title: AML 6889

value: neg

value: female

value: 36 years

value: cytogenetic good


title: AML 6952

value: 52 years

value: wild type

value: NN


title: AML 6976

value: 31 years

value: FAB M0

value: cytogenetic intermediate


title: AML 6955

value: Acute myeloid leukemia

value: Neg


title: AML 7055

value: blasts and mononuclear cells

value: 43 years


title: AML 6948

value: male

value: 22 years

value: FAB M5

value: cytogenetic poor

value: Pos


title: AML 6977

value: neg

value: 33 years

value: Other


title: AML 7059

value: pos

value: female

value: wild type


title: AML 6982

value: 47 years

value: FAB M1


title: AML 6974

value: Acute myeloid leukemia

value: 32 years

value: FAB M6

value: cytogenetic intermediate

value: nd


title: AML 7063

value: blasts and mononuclear cells

value: male

value: 48 years

value: FAB M3

value: cytogenetic good

value: Neg


title: AML 7053

value: neg

value: 29 years

value: cytogenetic poor


title: AML 6949

value: female

value: 33 years

value: wild type

value: NN

value: Pos


title: AML 7062

value: Acute myeloid leukemia

value: 53 years

value: FAB M2


title: AML 6945

value: blasts and mononuclear cells

value: FAB M4

value: cytogenetic intermediate


title: AML 6953

value: male

value: 55 years

value: FAB M6


title: AML 7057

value: neg

value: 56 years

value: FAB M1

value: Neg


title: AML 6890

value: female

value: 37 years

value: FAB M3

value: cytogenetic good

value: failure


title: AML 6975

value: Acute myeloid leukemia

value: 54 years

value: double mutant

value: Pos

value: pos


title: AML 6979

value: blasts and mononuclear cells

value: male

value: FAB M2

value: cytogenetic intermediate

value: wild type

value: NN


title: AML 7054

value: neg

value: 44 years

value: FAB M4

value: cytogenetic poor

value: Complex

value: Neg


title: AML 6947

value: Acute myeloid leukemia

value: 21 years

value: FAB M1

value: Other


title: AML 6714

value: female

value: 47 years

value: FAB M5

value: Pos


title: AML 6888

value: blasts and mononuclear cells

value: 43 years


title: AML 6883

value: male

value: 42 years

value: cytogenetic intermediate

value: wild type


title: AML 6885

value: neg

value: NN


title: AML 6375

value: 58 years

value: FAB unknown

value: cytogenetic poor

value: Neg


title: AML 6236

value: Acute myeloid leukemia

value: 59 years

value: FAB M2


title: AML 6365

value: female

value: 56 years

value: FAB M4

value: cytogenetic good


title: AML 6366

value: blasts and mononuclear cells

value: 57 years

value: Complex

value: Pos


title: AML 5363

value: pos

value: neg

value: 55 years

value: cytogenetic intermediate

value: wild type


title: AML 6884

value: 19 years

value: Other

value: Neg


title: AML 6448

value: Acute myeloid leukemia

value: male

value: 50 years

value: RAEB-t


title: AML 6887

value: female

value: 41 years

value: FAB M1

value: NN


title: AML 6364

value: blasts and mononuclear cells

value: 49 years

value: FAB M5

value: cytogenetic poor


title: AML 6369

value: pos

value: neg

value: 53 years

value: FAB M2

value: cytogenetic intermediate

value: Pos


title: AML 5364

value: Acute myeloid leukemia

value: male

value: 60 years

value: double mutant

value: Neg


title: AML 6368

value: female

value: wild type


title: AML 6378

value: blasts and mononuclear cells

value: 47 years

value: FAB M4

value: NN


title: AML 6373

value: 56 years

value: RAEB-t

value: cytogenetic poor

value: MDS complex


title: AML 5358

value: neg

value: 40 years

value: FAB M5


title: AML 6370

value: Acute myeloid leukemia

value: pos

value: 57 years

value: FAB M1

value: cytogenetic intermediate


title: AML 5359

value: female

value: 53 years

value: FAB M2

value: wild type

value: Neg

value: Pos


title: AML 6360

value: blasts and mononuclear cells

value: 30 years


title: AML 6371

value: male

value: 43 years


title: AML 6372

value: neg

value: 41 years

value: cytogenetic good


title: AML 6362

value: Acute myeloid leukemia

value: 29 years

value: single mutant

value: NN

value: nd


title: AML 6374

value: 55 years

value: cytogenetic intermediate


title: AML 6367

value: 48 years

value: FAB M1

value: cytogenetic poor

value: wild type


title: AML 6379

value: blasts and mononuclear cells

value: 50 years

value: FAB M4

value: Pos

value: Neg


title: AML 6363

value: neg

value: female

value: 23 years

value: cytogenetic good

value: Pos?


title: AML 5362

value: Acute myeloid leukemia

value: male

value: 53 years

value: FAB M2

value: double mutant

value: NN

value: pos


title: AML 4337

value: blasts and mononuclear cells

value: 56 years

value: FAB M0

value: cytogenetic poor

value: wild type


title: AML 5356

value: neg

value: 40 years

value: FAB unknown

value: Neg

value: Pos


title: AML 7407

value: Acute myeloid leukemia

value: 38 years

value: FAB M5

value: cytogenetic intermediate


title: AML 5357

value: male

value: 43 years

value: FAB M2

value: cytogenetic good


title: AML 5282

value: blasts and mononuclear cells

value: female

value: 56 years

value: NN


title: AML 4339

value: pos

value: neg

value: 20 years

value: RAEB

value: wild type


title: AML 7319

value: Acute myeloid leukemia

value: 60 years

value: FAB M4

value: Pos

value: Neg


title: AML 7317

value: 37 years

value: RAEB-t

value: cytogenetic poor

value: Other


title: AML 4338

value: blasts and mononuclear cells

value: male

value: 50 years

value: FAB M0

value: cytogenetic intermediate


title: AML 4336

value: neg

value: 30 years

value: double mutant

value: NN

value: pos


title: AML 7406

value: Acute myeloid leukemia

value: female

value: 25 years

value: FAB M1


title: AML 4340

value: 39 years

value: FAB M2

value: wild type

value: Neg


title: AML 7314

value: blasts and mononuclear cells

value: 41 years

value: FAB M5

value: Pos


title: AML 4335

value: neg

value: 44 years

value: cytogenetic intermediate


title: AML 5283

value: male

value: 35 years

value: cytogenetic good


title: AML 7403

value: Acute myeloid leukemia

value: 46 years

value: FAB M4


title: AML 4341

value: 53 years

value: RAEB-t

value: single mutant

value: NN

value: pos


title: AML 7311

value: blasts and mononuclear cells

value: wild type

value: Neg


title: AML 5285

value: neg

value: 59 years

value: Pos


title: AML 7313

value: female

value: 56 years

value: FAB M0

value: cytogenetic poor


title: AML 7402

value: Acute myeloid leukemia

value: 22 years

value: cytogenetic good


title: AML 7310

value: 54 years

value: FAB M5

value: cytogenetic intermediate


title: AML 7318

value: male

value: 60 years

value: FAB unknown

value: NN


title: AML 7315

value: blasts and mononuclear cells

value: neg

value: 45 years

value: FAB M4

value: wild type

value: Neg


title: AML 7309

value: pos

value: female

value: RAEB-t

value: Pos


title: AML 4333

value: Acute myeloid leukemia

value: 31 years


title: AML 4334

value: 54 years

value: cytogenetic intermediate


title: AML 7405

value: male

value: 47 years

value: cytogenetic poor

value: Other


title: AML 7316

value: blasts and mononuclear cells

value: neg

value: 43 years

value: FAB M2

value: NN


title: AML 7308

value: 58 years

value: FAB M0

value: wild type

value: Neg


title: AML 7307

value: Acute myeloid leukemia

value: female

value: 39 years

value: FAB M1

value: Complex


title: AML 7305

value: 24 years

value: FAB M5

value: cytogenetic intermediate

value: Pos


title: AML 7306

value: blasts and mononuclear cells

value: neg

value: male

value: 51 years

value: cytogenetic poor


title: AML 7277

value: 31 years

value: FAB M4E

value: cytogenetic good


title: AML 7304

value: Acute myeloid leukemia

value: 60 years

value: FAB M2

value: wild type

value: Other

value: Neg


title: AML 7301

value: pos

value: female

value: 35 years

value: FAB M1

value: NN


title: AML 7303

value: blasts and mononuclear cells

value: neg

value: male

value: 38 years

value: RAEB-t

value: cytogenetic intermediate

value: MDS -Y


title: AML 7178

value: Acute myeloid leukemia

value: 28 years

value: FAB M5

value: unknown


title: AML 7302

value: 50 years

value: single mutant

value: Pos

value: Neg


title: AML 7276

value: pos

value: 59 years

value: FAB M4

value: cytogenetic poor

value: wild type


title: AML 7174

value: blasts and mononuclear cells

value: neg

value: male

value: 26 years

value: cytogenetic good


title: AML 7173

value: Acute myeloid leukemia

value: female

value: 46 years

value: FAB M2


title: AML 7185

value: 39 years

value: cytogenetic intermediate

value: single mutant

value: NN


title: AML 7183

value: pos

value: 51 years

value: FAB M5

value: Neg


title: AML 7172

value: blasts and mononuclear cells

value: 55 years

value: wild type

value: Pos


title: AML 7163

value: neg

value: male

value: 54 years

value: cytogenetic poor


title: AML 7177

value: Acute myeloid leukemia

value: RAEB-t

value: MDS -7(q)


title: AML 7150

value: female

value: 20 years

value: FAB M4

value: cytogenetic good


title: AML 7151

value: 32 years

value: FAB M1

value: cytogenetic intermediate

value: Other


title: AML 7149

value: blasts and mononuclear cells

value: 37 years

value: FAB M5

value: double mutant

value: NN

value: Neg

value: pos


title: AML 7145

value: Acute myeloid leukemia

value: neg

value: 50 years

value: FAB M2

value: unknown

value: wild type

value: failure

value: Pos


title: AML 7134

value: male

value: 35 years

value: FAB M3

value: cytogenetic good


title: AML 7153

value: blasts and mononuclear cells

value: female

value: 22 years

value: FAB M5

value: cytogenetic intermediate


title: AML 7142

value: Acute myeloid leukemia

value: 49 years

value: cytogenetic poor

value: double mutant

value: Neg

value: pos


title: AML 7154

value: neg

value: 48 years

value: FAB M1

value: wild type

value: Other


title: AML 7131

value: 55 years

value: unknown

value: failure

value: Pos


title: AML 7137

value: blasts and mononuclear cells

value: male

value: 58 years

value: FAB M5


title: AML 7143

value: Acute myeloid leukemia

value: 27 years

value: FAB unknown

value: cytogenetic intermediate

value: NN


title: AML 7147

value: pos

value: neg

value: 59 years

value: Neg


title: AML 7114

value: 54 years

value: FAB M2

value: cytogenetic good

value: wild type


title: AML 7139

value: blasts and mononuclear cells

value: female

value: 53 years

value: FAB M4


title: AML 7082

value: Acute myeloid leukemia

value: 29 years

value: FAB M1

value: cytogenetic poor


title: AML 7115

value: 39 years


title: AML 7125

value: 48 years

value: cytogenetic intermediate

value: NN

value: Pos


title: AML 7127

value: neg

value: male

value: 44 years

value: double mutant

value: Neg

value: pos


title: AML 7124

value: blasts and mononuclear cells

value: female

value: 59 years

value: FAB M5

value: wild type


title: AML 6880

value: Acute myeloid leukemia

value: FAB M2

value: cytogenetic poor

value: Other


title: AML 6735

value: 55 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 7081

value: neg

value: male

value: 43 years

value: cytogenetic good


title: AML 6734

value: blasts and mononuclear cells

value: Neg


title: AML 6724

value: 26 years

value: Pos


title: AML 6881

value: female

value: 37 years

value: FAB M4

value: wild type

value: failure


title: AML 6732

value: Acute myeloid leukemia

value: 38 years

value: FAB M5


title: AML 6723

value: 32 years

value: cytogenetic intermediate

value: Other


title: AML 6730

value: neg

value: male

value: 49 years

value: FAB M3

value: NN


title: AML 6246

value: blasts and mononuclear cells

value: 25 years

value: FAB M1

value: Neg


title: AML 6717

value: 58 years

value: cytogenetic good

value: wild type


title: AML 6247

value: Acute myeloid leukemia

value: 60 years

value: FAB M2

value: single mutant

value: Pos

value: pos


title: AML 6237

value: neg

value: female

value: 59 years

value: cytogenetic intermediate


title: AML 6464

value: blasts and mononuclear cells


title: AML 5365

value: 42 years

value: FAB M4


title: AML 5286

value: male

value: 57 years

value: NN

value: Neg


title: AML 6720

value: Acute myeloid leukemia

value: 38 years

value: FAB M1

value: wild type


title: AML 6719

value: 33 years

value: FAB M2

value: cytogenetic good


title: AML 6721

value: neg

value: 39 years

value: FAB M5

value: Pos


title: AML 6376

value: blasts and mononuclear cells

value: female

value: 36 years

value: cytogenetic intermediate

value: double mutant

value: pos


title: AML 6882

value: Acute myeloid leukemia

value: male

value: 37 years

value: NN

value: Neg


title: AML 6715

value: FAB M4E

value: wild type


title: AML 6239

value: neg

value: 42 years

value: FAB M2


title: AML 7128

value: 59 years

value: FAB M5

value: Other

value: Pos


title: AML 6358

value: blasts and mononuclear cells

value: female

value: 45 years

value: cytogenetic poor


title: AML 2688

value: Acute myeloid leukemia

value: male

value: 40 years

value: FAB unknown

value: cytogenetic intermediate


title: AML 3310

value: pos

value: 55 years

value: wild type

value: NN

value: Neg


title: AML 3328

value: neg

value: 41 years

value: FAB M5


title: AML 3482

value: blasts and mononuclear cells

value: 43 years

value: Pos


title: AML 2694

value: 45 years

value: cytogenetic poor

value: Other


title: AML 3483

value: Acute myeloid leukemia

value: male

value: FAB M1


title: AML 3484

value: female

value: 60 years

value: FAB M4

value: cytogenetic intermediate


title: AML 3323

value: 37 years

value: wild type

value: Neg


title: AML 3481

value: pos

value: neg

value: 46 years

value: RAEB


title: AML 3327

value: blasts and mononuclear cells

value: 59 years

value: double mutant

value: NN

value: Pos


title: AML 3325

value: Acute myeloid leukemia

value: 41 years


title: AML 3324

value: male

value: 26 years

value: FAB M5

value: cytogenetic good


title: AML 3326

value: 60 years

value: FAB M2

value: cytogenetic intermediate

value: wild type

value: Other


title: AML 3334

value: neg

value: female

value: 43 years

value: RAEB-t

value: Neg


title: AML 3314

value: blasts and mononuclear cells

value: 31 years

value: FAB unknown

value: cytogenetic poor

value: Complex


title: AML 3313

value: Acute myeloid leukemia

value: male

value: 49 years

value: FAB M0


title: AML 3312

value: 19 years

value: FAB M2

value: cytogenetic intermediate

value: Pos


title: AML 3322

value: neg

value: female

value: 34 years

value: FAB M5

value: wild type


title: AML 3316

value: blasts and mononuclear cells

value: 43 years

value: Other

value: Neg


title: AML 3304

value: Acute myeloid leukemia

value: 58 years

value: NN


title: AML 3318

value: male

value: 53 years

value: cytogenetic poor


title: AML 3321

value: 36 years

value: cytogenetic intermediate


title: AML 3308

value: neg

value: pos

value: 32 years

value: FAB M1

value: Pos


title: AML 3311

value: blasts and mononuclear cells

value: female

value: 59 years

value: FAB M5

value: wild type


title: AML 3309

value: Acute myeloid leukemia

value: FAB M4

value: cytogenetic good

value: Neg


title: AML 3315

value: male

value: 35 years

value: RAEB-t

value: cytogenetic poor

value: MDS -7(q)


title: AML 3317

value: neg

value: 25 years

value: cytogenetic intermediate

value: Other


title: AML 3289

value: blasts and mononuclear cells

value: 46 years

value: FAB M2

value: Pos


title: AML 3301

value: Acute myeloid leukemia

value: 56 years

value: FAB M5

value: wild type


title: AML 3320

value: male

value: 51 years

value: FAB M1

value: NN

value: Neg


title: AML 3286

value: neg

value: 55 years

value: FAB M4

value: cytogenetic good


title: AML 3295

value: blasts and mononuclear cells

value: female

value: 42 years


title: AML 3115

value: 57 years


title: AML 3292

value: Acute myeloid leukemia

value: 41 years

value: FAB M2


title: AML 3285

value: 26 years

value: wild type

value: Pos


title: AML 3277

value: 28 years

value: FAB M1


title: AML 2766

value: male

value: Neg


title: AML 3279

value: neg

value: 22 years

value: FAB M3


title: AML 2769

value: blasts and mononuclear cells

value: pos

value: 55 years

value: cytogenetic intermediate

value: NN


title: AML 3278

value: Acute myeloid leukemia

value: female

value: 52 years

value: cytogenetic good


title: AML 2767

value: 36 years

value: unknown

value: wild type

value: failure

value: Pos


title: AML 2764

value: neg

value: male

value: 21 years

value: FAB M2

value: Neg


title: AML 2752

value: blasts and mononuclear cells

value: 16 years


title: AML 2692

value: 42 years

value: FAB M5

value: cytogenetic intermediate

value: NN


title: AML 2754

value: Acute myeloid leukemia

value: 28 years

value: FAB M1


title: AML 2749

value: 38 years

value: wild type


title: AML 2687

value: female

value: 53 years

value: Pos


title: AML 2765

value: neg

value: pos

value: 33 years

value: Other


title: AML 2748

value: blasts and mononuclear cells

value: 47 years

value: FAB M4

value: double mutant

value: Neg


title: AML 2690

value: Acute myeloid leukemia

value: 16 years

value: FAB M2

value: cytogenetic intermediate


title: AML 2762

value: male

value: 23 years

value: cytogenetic good

value: wild type


title: AML 2756

value: neg

value: 37 years

value: NN

value: Pos


title: AML 2753

value: blasts and mononuclear cells

value: 34 years

value: FAB M1


title: AML 2685

value: pos

value: female

value: 42 years

value: FAB M4


title: AML 2747

value: Acute myeloid leukemia

value: 22 years

value: FAB M5

value: cytogenetic poor

value: Neg


title: AML 2750

value: 40 years

value: FAB M2

value: cytogenetic good

value: wild type


title: AML 2757

value: neg

value: male

value: 52 years


title: AML 2695

value: blasts and mononuclear cells

value: 37 years

value: FAB M1


title: AML 2771

value: cytogenetic intermediate

value: NN

value: Pos


title: AML 2683

value: Acute myeloid leukemia

value: female

value: 59 years


title: AML 2751

value: 31 years

value: Neg


title: AML 2689

value: pos

value: 53 years

value: FAB M4


title: AML 2676

value: neg

value: 47 years

value: FAB M2

value: unknown

value: wild type

value: failure


title: AML 2680

value: blasts and mononuclear cells

value: 32 years

value: cytogenetic good


title: AML 2670

value: Acute myeloid leukemia

value: male

value: FAB M5

value: cytogenetic poor

value: Pos


title: AML 2679

value: pos

value: female

value: 39 years

value: cytogenetic intermediate

value: NN

value: Neg


title: AML 2696

value: neg

value: 46 years

value: FAB M4


title: AML 2682

value: blasts and mononuclear cells

value: 56 years

value: wild type

value: Other


title: AML 2672

value: Acute myeloid leukemia

value: male

value: 47 years


title: AML 2678

value: 15 years

value: cytogenetic good


title: AML 2671

value: 38 years

value: FAB M3

value: Pos


title: AML 2665

value: female

value: 45 years

value: FAB M5

value: cytogenetic poor


title: AML 2666

value: neg

value: 35 years

value: unknown

value: failure

value: Neg


title: AML 2668

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 41 years

value: FAB M0

value: wild type

value: Complex


title: AML 2644

value: male

value: 59 years

value: FAB M1

value: cytogenetic intermediate

value: NN


title: AML 2545

value: 24 years

value: double mutant

value: Pos


title: AML 2551

value: neg

value: female

value: 23 years

value: FAB M5

value: Other


title: AML 2664

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 33 years

value: cytogenetic poor

value: Neg


title: AML 2550

value: pos

value: male

value: 55 years

value: wild type


title: AML 2669

value: 45 years

value: cytogenetic intermediate

value: NN


title: AML 2543

value: neg

value: 52 years

value: FAB M2


title: AML 2542

value: female

value: 20 years

value: FAB M4

value: Pos


title: AML 2534

value: Acute myeloid leukemia

value: blasts and mononuclear cells

value: 58 years

value: Complex


title: AML 2549

value: male

value: 26 years

value: cytogenetic good

value: Neg


title: AML 2535

value: 38 years

value: FAB M5

value: cytogenetic poor

value: wild type


title: AML 2544

value: neg

value: pos

value: 37 years

value: FAB M2

value: cytogenetic intermediate


title: AML 2658

value: Acute myeloid leukemia

value: female

value: 33 years

value: FAB M4